nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bridge to comfort: Palliative inotrope infusion for patients with heart failure in hospice care
|
Pichan, Cayla M. |
|
|
275 |
C |
p. 105-107 |
artikel |
2 |
Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis
|
Kusner, Jonathan |
|
|
275 |
C |
p. 1-8 |
artikel |
3 |
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study
|
Kercheval, Jacquelyn B. |
|
|
275 |
C |
p. 183-190 |
artikel |
4 |
Corrigendum to “Right atrial dysfunction is associated with atrial arrhythmias in adults with repaired tetralogy of Fallot” [American Heart Journal Volume 263 (2023)141-150]
|
Egbe, Alexander C. |
|
|
275 |
C |
p. 191 |
artikel |
5 |
Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk prediction
|
Lindley, Kathryn J. |
|
|
275 |
C |
p. 192-199 |
artikel |
6 |
Design and rationale of the cardiometabolic health program linked with community health workers and mobile health telemonitoring to reduce health disparities (LINKED-HEARTS) program
|
Commodore-Mensah, Yvonne |
|
|
275 |
C |
p. 9-20 |
artikel |
7 |
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction
|
d'Entremont, Marc-André |
|
|
275 |
C |
p. 173-182 |
artikel |
8 |
Design and rationale of the social determinants of the risk of hypertension in women of reproductive age (SAFE HEART) study: An American Heart Association research goes red initiative
|
Metlock, Faith E. |
|
|
275 |
C |
p. 151-162 |
artikel |
9 |
Echocardiographic and clinical features of patients developing prosthesis‐patient mismatch after transcatheter aortic valve replacement: Insights from the Recovery-TAVR registry
|
Bruno, Francesco |
|
|
275 |
C |
p. 128-137 |
artikel |
10 |
Editorial Board
|
|
|
|
275 |
C |
p. iii-iv |
artikel |
11 |
Framework of the strengths and challenges of clinically integrated trials: An expert panel report
|
Peters, Anthony E. |
|
|
275 |
C |
p. 62-73 |
artikel |
12 |
Fully automated quantitative coronary angiography versus optical coherence tomography guidance for coronary stent implantation (FLASH): Study protocol for a randomized controlled noninferiority trial
|
Kim, Yongcheol |
|
|
275 |
C |
p. 86-95 |
artikel |
13 |
Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantation
|
Miyawaki, Norihisa |
|
|
275 |
C |
p. 141-150 |
artikel |
14 |
Incident stroke in individuals with peripartum cardiomyopathy
|
Ibeh, Chinwe |
|
|
275 |
C |
p. 138-140 |
artikel |
15 |
Information for Readers
|
|
|
|
275 |
C |
p. v |
artikel |
16 |
Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial)
|
Rwebembera, Joselyn |
|
|
275 |
C |
p. 74-85 |
artikel |
17 |
Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system
|
Lupu, Lior |
|
|
275 |
C |
p. 21-34 |
artikel |
18 |
Prediction of 30‐day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study
|
Gatti, Giuseppe |
|
|
275 |
C |
p. 108-118 |
artikel |
19 |
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial
|
Richardson, Carla |
|
|
275 |
C |
p. 119-127 |
artikel |
20 |
REGENERATE-COBRA: A phase II randomized sham-controlled trial assessing the safety and efficacy of intracoronary administration of autologous bone marrow-derived cells in patients with refractory angina
|
Ramaseshan, Rohini |
|
|
275 |
C |
p. 96-104 |
artikel |
21 |
Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial
|
Jeyaprakash, Prajith |
|
|
275 |
C |
p. 163-172 |
artikel |
22 |
Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50%
|
Bockus, Lee B. |
|
|
275 |
C |
p. 35-44 |
artikel |
23 |
Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial
|
Song, Lei |
|
|
275 |
C |
p. 53-61 |
artikel |
24 |
Table of Contents
|
|
|
|
275 |
C |
p. i-ii |
artikel |
25 |
The relative merits of using a high-sensitivity cardiac Troponin T assay compared to a nonhigh-sensitivity troponin T assay after noncardiac surgery
|
Borges, Flavia K. |
|
|
275 |
C |
p. 45-52 |
artikel |